共 50 条
Mucosal Vaccination with a Self-Adjuvanted Lipopeptide Is Immunogenic and Protective against Mycobacterium tuberculosis
被引:21
作者:
Ashhurst, Anneliese S.
[1
,2
]
McDonald, David M.
[1
]
Hanna, Cameron C.
[1
]
Stanojevic, Vicki A.
[1
]
Britton, Warwick J.
[2
,3
]
Payne, Richard J.
[1
]
机构:
[1] Univ Sydney, Sch Chem, Camperdown, NSW 2050, Australia
[2] Univ Sydney, TB Res Program Centenary Inst, Camperdown, NSW 2050, Australia
[3] Univ Sydney, Fac Med & Hlth, Camperdown, NSW 2050, Australia
基金:
英国医学研究理事会;
关键词:
MULTIDRUG-RESISTANT TUBERCULOSIS;
SOLID-PHASE SYNTHESIS;
IMMUNOLOGICAL EVALUATION;
EPIDEMIC SPREAD;
TH17;
CELLS;
PEPTIDE;
VACCINES;
BCG;
IMMUNIZATION;
INFECTION;
D O I:
10.1021/acs.jmedchem.9b00832
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Tuberculosis (TB) remains a staggering burden on global public health. Novel preventative tools are desperately needed to reach the targets of the WHO post-2015 End-TB Strategy. Peptide or protein-based subunit vaccines offer potential as safe and effective generators of protection, and enhancement of local pulmonary immunity may be achieved by mucosal delivery. We describe the synthesis of a novel subunit vaccine via native chemical ligation. Two immunogenic epitopes, ESAT6(1_20) and TB10.4(3-11) from Mycobacterium tuberculosis (Mtb), were covalently conjugated to the TLR2-ligand Pam(2)Cys to generate a self-adjuvanting lipopeptide vaccine. When administered mucosally to mice, the vaccine enhanced pulmonary immunogenicity, inducing strong Th17 responses in the lungs and multifunctional peripheral T-lymphocytes. Mucosal, but not peripheral vaccination, provided substantial protection against Mtb infection, emphasizing the importance of delivery route for optimal efficacy.
引用
收藏
页码:8080 / 8089
页数:10
相关论文